Won Jun Kim

6PUBLICATIONS
133CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 01, 2024
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.

Skye Montoya, Jessie Bourcier, Mark Noviski

|Jan 17, 2024
Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.

Andrew J Dunbar, Robert L Bowman, Young C Park

|Feb 09, 2023
Acquired BAX mutations in AML.

Won Jun Kim, Omar Abdel-Wahab

|Jul 29, 2022
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation.

Sisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro

Pageof 1